Tarsus Pharmaceuticals, Inc.
TARS
$40.81
$1.995.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 36.64% | 28.11% | 28.38% | 81.55% | 48.36% |
| Total Receivables | 104.56% | 171.31% | 375.73% | 12,436.99% | 974.74% |
| Inventory | -32.98% | -15.67% | 18,873.33% | -- | -- |
| Prepaid Expenses | -11.82% | 86.20% | 16.78% | 19.39% | 50.88% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 41.10% | 39.27% | 37.74% | 97.62% | 63.30% |
|
|
|||||
| Total Current Assets | 41.10% | 39.27% | 37.74% | 97.62% | 63.30% |
| Net Property, Plant & Equipment | -8.36% | -14.40% | 15.72% | 14.46% | 100.23% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 114.65% | 115.31% | 115.96% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 333.64% | 372.77% | 189.92% | 151.79% | 200.68% |
| Total Assets | 43.37% | 42.00% | 40.24% | 99.47% | 65.37% |
|
|
|||||
| Total Accounts Payable | 48.28% | 56.08% | 158.28% | 226.15% | 153.00% |
| Total Accrued Expenses | 115.75% | 37.73% | 81.44% | 38.14% | 29.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -34.36% | 52.76% | 49.17% | 40.37% | -16.79% |
| Total Finance Division Other Current Liabilities | 166.71% | 580.54% | 500.79% | -- | 116,914.29% |
| Total Other Current Liabilities | 166.71% | 580.54% | 500.79% | -- | 116,914.29% |
| Total Current Liabilities | 102.94% | 118.25% | 183.32% | 249.28% | 220.84% |
|
|
|||||
| Total Current Liabilities | 102.94% | 118.25% | 183.32% | 249.28% | 220.84% |
| Long-Term Debt | 140.48% | 140.94% | 141.38% | 190.88% | 22.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -25.61% | -20.17% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 113.71% | 122.56% | 153.93% | 202.44% | 95.89% |
|
|
|||||
| Common Stock & APIC | 30.96% | 32.36% | 37.90% | 81.82% | 81.79% |
| Retained Earnings | -37.43% | -47.23% | -66.26% | -91.73% | -112.12% |
| Treasury Stock & Other | 234.92% | 9,050.00% | 4,425.00% | -665.22% | 10.00% |
| Total Common Equity | 24.43% | 13.98% | 11.15% | 70.75% | 58.71% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 24.43% | 13.98% | 11.15% | 70.75% | 58.71% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 24.43% | 13.98% | 11.15% | 70.75% | 58.71% |
|
|
|||||